Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2026 Oct 5;28(10):e70644. doi: 10.1111/codi.70644

A systematic review and meta‐analysis of preoperative MRI‐based pelvimetry in predicting surgical difficulty in rectal cancer: Implications for personalised surgical planning

Daichi Kitaguchi 1,2,✉, Fiona R Kolbinger 3,4, Paul Dipanjyoti 5, Kshitij Jadhav 6, Tatsuya Oda 1, Antonello Forgione 2, Jacques Marescaux 2
PMCID: PMC13639373  PMID: 42834699

Abstract

Background

Magnetic resonance imaging (MRI)‐based pelvimetry has been investigated for predicting surgical difficulty in total mesorectal excision (TME) for rectal cancer. However, heterogeneity in pelvimetric parameters, surrogate outcomes, and study design has resulted in inconsistent evidence. This systematic review aimed to synthesise the evidence on commonly used MRI parameters and difficulty surrogates and assess their methodological robustness and clinical relevance.

Methods

PubMed, Embase, and the Cochrane Library were systematically searched through December 2025 for studies evaluating preoperative MRI pelvimetry in patients undergoing TME for rectal cancer. Outcome parameters were surrogate measures of surgical difficulty, including operating time, intraoperative blood loss, conversion to open surgery, pathological quality metrics, and postoperative complications. Risk of bias was assessed using the Risk of Bias in Non‐randomised Studies of Exposures (ROBINS‐E) tool. This systematic review and meta‐analysis was reported in accordance with the PRISMA 2020 statement and prospectively registered (PROSPERO: CRD420261287153).

Results

Thirty‐six studies comprising 8,364 patients were included. Common parameters included sagittal measurements and axial interspinous distance (ISD) and intertuberous distance (ITD). Definitions of surgical difficulty varied substantially. ROBINS‐E identified some concerns in 30 studies, a high risk of bias in five, and insufficient information in one. Meta‐analysis of six studies (n = 769) showed that shorter ISD (mean difference [MD] −5.13 mm, 95% CI −6.61 to −3.65; p < 0.001; I 2 = 0%) and ITD (MD −7.32 mm, 95% CI −10.24 to −4.39; p = 0.004; I 2 = 0%) were significantly associated with surrogate measures of surgical difficulty.

Conclusions

MRI‐based pelvimetry, particularly ISD and ITD, may help predict surgical difficulty in TME. However, methodological heterogeneity limits broader quantitative synthesis and highlights the need for standardised pelvimetric protocols.

Keywords: magnetic resonance imaging, pelvimetry, rectal neoplasms, surgical difficulty, systematic review, total mesorectal excision


What does this paper add to the literature?

This systematic review synthesises heterogeneous evidence on MRI‐based pelvimetry for predicting surgical difficulty in total mesorectal excision. It identifies interspinous and intertuberous distances as the pelvimetric parameters most consistently associated with surrogate measures of surgical difficulty and highlights the need for standardised pelvimetric parameters and definitions of surgical difficulty.

INTRODUCTION

Since the 1980s, total mesorectal excision (TME) has substantially improved oncological outcomes in rectal cancer surgery [1, 2]. Following the adoption of minimally invasive techniques, randomised controlled trials (RCTs) in the 2010s, including the COLOUR II and COREAN trials, demonstrated the non‐inferiority of laparoscopic TME compared with open surgery [3, 4, 5, 6, 7]. However, other RCTs involving more technically challenging cases, such as ACOSOG Z6051 and ALaCaRT, failed to demonstrate non‐inferiority based on composite measures of successful resection, including circumferential and distal margin status and completeness of TME [8, 9, 10, 11]. These findings reflect the technical limitations of conventional laparoscopic TME, particularly in patients with a high body mass index (BMI) or a narrow pelvis. Alternative approaches, including robotic TME and transanal total mesorectal excision (TaTME), were developed to address these limitations, and recent RCTs have demonstrated their non‐inferiority compared with conventional laparoscopic TME [12, 13, 14, 15].

Concurrently, neoadjuvant treatment strategies have evolved, shifting from conventional chemoradiotherapy (CRT) toward total neoadjuvant therapy (TNT), alongside growing interest in organ preservation [16, 17, 18, 19, 20]. Nevertheless, the 2025 update of the European Society for Medical Oncology (ESMO) rectal cancer guidelines emphasised that routine preoperative radiotherapy for all patients remains controversial, given the low risk of local recurrence reported in selected patients undergoing high‐quality TME [21]. Consequently, both the surgical approach and treatment strategy now require individualised, case‐by‐case decision‐making that accounts for anatomical complexity and technical difficulty.

Against this background, magnetic resonance imaging (MRI)‐based pelvimetry has been extensively investigated as a component of multifactorial preoperative risk assessment for predicting surrogate measures of surgical difficulty during TME for rectal cancer [22]. However, substantial heterogeneity in pelvimetric parameters, study designs, and the surrogate outcomes used to define surgical difficulty—which span intraoperative, postoperative, and pathological/oncological domains—has resulted in fragmented evidence. This fragmentation is further compounded by evolving surgical techniques and the emergence of artificial intelligence (AI)‐based image analysis. Therefore, this systematic review aimed to synthesise the existing evidence on MRI‐based pelvimetry by evaluating commonly used parameters and difficulty surrogates, assessing their methodological rigour and clinical relevance, and examining their applicability to contemporary surgical practice and future AI‐driven image analysis frameworks.

MATERIALS AND METHODS

Study design

This systematic review was reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) 2020 guidelines [23]. A prospective protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO; registration number CRD420261287153) before data extraction.

Search strategy

A comprehensive literature search was conducted in PubMed, Embase, and the Cochrane Library to identify relevant English‐language publications from database inception through December 2025. A core search strategy was developed using a combination of free‐text keywords and controlled vocabulary terms related to rectal cancer, MRI, pelvimetry‐related anatomical parameters, surgical procedures, and surgery‐related outcomes. The baseline free‐text search strategy was as follows: (rectal cancer OR rectal carcinoma*) AND (MRI OR “magnetic resonance”) AND (pelvis OR pelvic OR pelvimetry OR intertuberous OR interspinous OR “pelvic dimension” OR “pelvic anatomy” OR “mesorectal fat” OR “mesorectal area”) AND (surgery OR surgical) AND (“operative time” OR “blood loss” OR “postoperative complication” OR difficult* OR “surgical difficulty” OR conversion OR “circumferential resection margin” OR CRM OR “specimen quality” OR “TME quality”). This core strategy was subsequently adapted for each database by incorporating appropriate controlled vocabulary (e.g., Medical Subject Headings [MeSH] in PubMed and Emtree terms in Embase) and applying database‐specific syntax. The complete search strategies for all databases are provided in Table S1, and the final search was updated in December 2025.

Eligibility criteria

Studies were considered eligible for inclusion if they met all of the following criteria:

  1. involved adult patients undergoing TME for rectal cancer;

  2. reported both preoperative MRI–based pelvimetry and surgery‐related outcomes reflecting surgical difficulty; and

  3. were full‐text, peer‐reviewed articles published in English

  1. used computed tomography (CT)‐based pelvimetry exclusively without reporting surgical (surrogate) outcomes;

  2. evaluated exclusively long‐term oncological outcomes without reporting surgery‐related or surgical difficulty‐related outcomes; or

  3. were non‐original publications (e.g., reviews, editorials, conference abstracts, or case reports) or lacked sufficient extractable methodological data.

Studies were excluded if they met any of the following criteria:

We restricted the imaging modality to MRI to minimise modality‐related heterogeneity and to enable assessment of both pelvic anatomy and relevant soft‐tissue structures.

Study selection

All records retrieved from the search were screened by one author based on titles and abstracts using predefined eligibility criteria, with all screening decisions independently verified by a second author. Studies deemed potentially eligible proceeded to full‐text assessment. Although formal inter‐reviewer agreement statistics were not calculated, disagreements at any stage were resolved through discussion and consensus. Reasons for exclusion at the full‐text stage were documented. Full‐text assessment followed the same screening process used for title and abstract screening and was conducted manually.

Risk‐of‐bias assessment

The risk of bias for all included studies was evaluated independently by two authors across all domains of the Risk of Bias in Non‐randomised Studies of Exposures (ROBINS‐E) tool [24]. ROBINS‐E was preferred over the Risk of Bias in Non‐randomised Studies of Interventions (ROBINS‐I) tool because the included studies examined MRI‐determined pelvic dimensions as inherent, non‐manipulable exposures rather than therapeutic interventions [25]. Any discrepancies were resolved through discussion, and consensus was achieved in all cases.

Data extraction

Data extraction encompassed all preoperative MRI pelvimetric parameters derived from anatomical landmarks used to measure pelvic distances, angles, areas or volumes. For each study, all pelvimetric parameters included in the analyses were recorded. Surgery‐related outcomes used as surrogate measures of surgical difficulty were also extracted. When studies reported multiple outcomes, each outcome was extracted and evaluated independently. Additionally, outcomes demonstrating statistically significant associations with surgical difficulty surrogates were identified and extracted separately. For each included study, the statistical methods used to analyse associations between pelvimetric parameters and surgical outcomes were documented.

Statistical analysis

Meta‐analyses were performed for homogeneous parameters, with results presented as forest plots. For continuous outcomes, the inverse variance method was applied, and results were expressed as mean differences (MDs) with 95% confidence intervals (CIs). Heterogeneity for each outcome was assessed using the chi‐squared (χ2) test (Cochran's Q) and inconsistency index (I 2). A χ2 p value of <0.10 or an I 2 value of >50% indicated substantial heterogeneity. A random‐effects model was used, with between‐study variance estimated using the restricted maximum likelihood (REML) method and CIs calculated using the Hartung–Knapp–Sidik–Jonkman (HKSJ) method. When continuous data were reported as medians with ranges or interquartile ranges (IQRs), means and standard deviations (SDs) were re‐estimated using previously described methods [26, 27]. To minimise conceptual heterogeneity across studies, meta‐analyses were restricted to a subset of studies that used composite outcomes as surrogate measures of surgical difficulty. These composite or predefined combinations of surrogate measures of surgical difficulty incorporated intraoperative and postoperative parameters and were conceptually based on the framework established by Escal et al. [28]. Although the specific components and thresholds varied across studies, studies were considered eligible for meta‐analysis when these measures represented broadly comparable clinical domains of surgical difficulty. Meta‐analyses were conducted using RevMan Web (Cochrane, London, UK).

RESULTS

Study selection

Figure 1 illustrates the PRISMA flow diagram of the study selection process. After screening, 36 articles met the eligibility criteria and were included in this systematic review (Table S2).

FIGURE 1.

FIGURE 1

Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) flow diagram of the study selection process.

Study characteristics

Table 1 presents the characteristics of the 36 included studies, comprising 8,364 patients whose preoperative MRI data were analysed. Most studies were conducted in East Asia (19/36) and Europe (11/36). A total of 26 studies (72%) used a single‐centre design, whereas 10 (28%) were conducted in a multicentre setting. The inclusion periods were explicitly reported in 33 studies; among these, 11 (33%) were initiated in the 2000s, 20 (61%) in the 2010s, and two (6%) in the 2020s. Surgical approaches were reported in 33 studies: laparoscopic surgery was included in 26 (79%), followed by open surgery in 11 (33%) and robotic surgery in 10 (30%). TaTME was included in three studies (9%).

TABLE 1.

Summary of characteristics of included studies.

Author and year Country Number of centres Sample size Study period Eligibility criteria Surgical approach Analysed pelvimetric parameters Surgical difficulty surrogate Statistical method Significant parameters
Atasoy 2018 Turkey Single‐centre 125 Oct 2008–Feb 2011 AV ≤10 cm; cT3–4/N+; TME; nCRT Open PI, ITD, Pelvic depth, Interacetabular distance, S1/S3 distance, S3/Coccyx distance, Tumour volume Operative time, Blood loss, CRM involvement, Anastomotic complications (AL) Univariate analysis and multivariable linear and logistic regression PI, ISD, Pelvic depth, Tumour volume
Ay 2025 Turkey Single‐centre 52 Jan 2017–Sep 2022 AV ≤15 cm; TME; nCRT Open, Laparoscopic PI, ITD (ISD), Pelvic depth Operative time, Blood loss, Length of hospital stay, Postoperative complications, Number of lymph nodes, TME quality Univariate analysis and multivariable logistic regression PI, ISD, Pelvic depth
Baek 2015 South Korea Single‐centre 182 Jan 2008–Aug 2010 AV ≤15 cm Robotic PI, ISD, SCD, PO, ITD, Sacral depth Operative time, Anastomotic complications, Postoperative complications, CRM involvement, Distal margin, Number of lymph nodes Univariate analysis and multivariable linear regression None
Baik 2008 South Korea Single‐centre 100 May 2005–Mar 2006 AV ≤10 cm Open PI, ISD, SCD, Sacral depth, Transverse distance TME quality, CRM involvement, Number of lymph nodes Univariate analysis and multivariable logistic regression PI, ISD
Baltus 2025 Netherlands 11 1707 Jan 2015–Dec 2021 Tumour below the sigmoidal take‐off Laparoscopic, Robotic, TaTME PI, SCD, PO, Sacrococcygeal angle NA Deep learning–based model (3D U‐Net) NA (deep learning model)
Boyle 2005 UK Single‐centre 126 Dec 1999–Jan 2002 AV ≤15 cm Open PI, ISD, SCD, PO, ITD, Pubic length, Pelvic midplane, Sacrococcygeal curve length, Sacrococcygeal curve area CRM involvement Univariate and correlation analysis ISD, ITD
Cai 2023 China Single‐centre 328 2016–2021 AV ≤10 cm; LAR with DST Laparoscopic Pelvic Morphology, Mesorectal Morphology, Tumour Morphology (Mask R‐CNN‐based segmentation) Number of stapler cartridges Deep learning–based model (3D CNN) with ROC analysis NA (deep learning model)
Chau 2020 Canada Single‐centre 92 2011–2017 AV ≤10 cm; LAR Laparoscopic PI, ISD, SCD, PO, ITD, Pubic length, Multiple pelvic angles, Pelvic midplane, AP distance, S1/5 distance TME quality, CRM involvement, Distal margin, Operative time, Conversion to open Multivariable linear and logistic regression S1/S5/Pubic bottom angle
Chen 2021 China Single‐centre 147 2015–2016 AV ≤10 cm; cT3–4/N+; LAR/ISR; nCRT Laparoscopic PI, ISD, SCD, PO, Pubic length, Sacral depth, Multiple pelvic angles, Pelvic depth, Mesorectal area, Rectal area Operative time, Blood loss, Conversion to open, Transanal conversion, Postoperative complications, Length of hospital stay Univariate analysis and multivariable logistic regression with nomogram ISD, Pubic top/S1/S3 angle
de'Angelis 2018 France 4 170 Jan 2010–Jan 2016 AV ≤12 cm; cStage I–III; TME; nCRT Laparoscopic PI, ISD, SCD, PO, ITD, Pubic length, Multiple pelvic angles, Pelvic depth, Mesorectal area, Rectal area, S1/S3 distance, S3/Coccyx distance, Sacrococcygeal curve length, Sacrococcygeal curve area, Pelvic area, Interacetabular distance Operative time, Blood loss, Conversion to open, Postoperative complication, Successful resection Univariate analysis and multivariable regression ISD, ITD, Pubic length
de'Angelis 2019 France 4 136 Jan 2010–Jan 2016 AV ≤12 cm; cStage II–III; LAR/ISR; nCRT Laparoscopic PI, ISD, SCD, PO, ITD, Pubic length, Multiple pelvic angles, Pelvic depth, Mesorectal area, Rectal area, S1/S3 distance, S3/Coccyx distance, Sacrococcygeal curve length, Sacrococcygeal curve area, Pelvic area, Interacetabular distance Operative time, Blood loss, Conversion to open, Transanal conversion, Postoperative complications, Length of hospital stay Univariate analysis and multivariable logistic regression ISD
de'Angelis 2020 France 5 141 Feb 2016–Jun 2019 AV ≤12 cm; cStage II–III; LAR/ISR; nCRT Laparoscopic ISD Operative time, Blood loss, Conversion to open, Transanal conversion, Postoperative complications, Length of hospital stay Descriptive and comparative analysis with ROC analysis ISD
Escal 2018 France Single‐centre 164 2005–2014 AV ≤15 cm; LAR/ISR; nCRT Open, Laparoscopic, Robotic PI, ISD, SCD, PO, ITD, Mesorectal area, Rectal area, Transverse distance, Prostate volume Operative time, Blood loss, Conversion to open, Transanal conversion, Postoperative complications, Length of hospital stay Univariate analysis and multivariable logistic regression ITD, Mesorectal area
Felsenreich 2023 USA Multicenter 347 NR Male; AV ≤6 cm; TME Robotic Mesorectal area CRM involvement, Distal margin, TME quality, Number of lymph nodes, Operative time, Intraoperative and postoperative complications, Length of hospital stay, Mortality, Readmission, Reoperation Univariate analysis and multivariable logistic regression None
Ferko 2016 Czech Republic Single‐centre 93 2011–2014 AV ≤10 cm; LAR/ISR Open, Laparoscopic PI, ISD, PO, ITD, Pubic length, Multiple pelvic angles, Transverse distance, S1/S3 distance, S3/Coccyx distance, Interacetabular distance CRM involvement, Distal margin, TME quality Univariate analysis and ordinal logistic regression S1/Pubic top/Pubic bottom angle
Foo 2020 Hong Kong Single‐centre 155 2013–2016 LAR with DST Laparoscopic, Robotic PI, ISD, SCD, PO, ITD Number of stapler cartridges Univariate analysis and multivariable linear and logistic regression PI, ISD, ITD
Hong 2021 Australia Multicentre 34 NR TME Open, Laparoscopic ISD, SCD, ITD, Sacral depth, Rectal area, Pelvic area/volume, AP distance CRM involvement Univariate analysis and multivariable logistic regression Pelvic volume
Huang 2025 China Single‐center 264 Mar 2020–Mar 2024 Male; AV ≤7 cm; cStage I–III; LAR/ISR Laparoscopic S5/Anus/Urethral (SAU) angle Operative time, Blood loss, TME quality, Anastomotic complications (AL) Descriptive and univariate analysis S5/Anus/Urethral (SAU) angle
Jiang 2025 China 2 1367 Jan 2018–Dec 2024 AV ≤10 cm; cT1–3; M0; LAR/ISR Laparoscopic, Robotic PI, ISD, SCD, PO, ITD, Pubic length, Sacral depth, Mesorectal area, Rectal area, Transverse distance, AP distance Postoperative complications Univariate analysis and multivariable logistic regression with machine learning–based models and nomogram ISD, ITD
Killeen 2010 UK Single‐centre 25 NR TME Laparoscopic PI, ISD, PO, ITD, Multiple pelvic angles, S1/S3 distance, S3/Coccyx distance, Interacetabular distance Operative time, CRM involvement Descriptive and univariate correlation analysis PI, ITD, PO, Sacrococcygeal angle, S3/Coccyx/Pubic bottom angle
Kim 2011 South Korea Single‐centre 74 Apr 2008–Jul 2009 cT3–4/N+; M0; LAR with DST Laparoscopic PI, ISD, SCD, ITD, Sacral depth Pelvic dissection time, Blood loss, Tumour perforation, TME quality Univariate analysis and multivariable linear regression SCD, ITD, Sacral depth
Kuo 2025 Taiwan Single‐centre 527 Jan 2020–Dec 2023 AV ≤12 cm; LAR/ISR Laparoscopic, Robotic PI, ISD, SCD, PO, ITD, Pubic length, Sacral depth, Multiple pelvic angles, Pelvic depth, Mesorectal area, Transverse distance Anastomotic complications Univariate analysis and multivariable logistic regression with ROC analysis ISD, Pubic top/S1/Coccyx angle
Lee 2020 South Korea Single‐centre 85 Jan 2015–Dec 2015 AV ≤8 cm; cStage I–III; TME Open, Laparoscopic, Robotic Multiple pelvic floor muscle distances Operative time Univariate analysis and multivariable linear regression Incline angle of pelvic floor muscle
Ma 2019 China Multicenter 125 Jun 2010–Feb 2015 AV ≤12 cm; cStage II–III; LAR/ISR; nCRT/nCT NR Multiple pelvic muscle thicknesses, Rectal wall thickness, Distal sigmoid colon thickness, Mesorectal area Anastomotic complications (AL) Univariate analysis and multivariable regression with ROC analysis Rectal wall thickness, Distal sigmoid colon thickness, Posterior mesorectal thickness
Ma 2022 China Single‐centre 221 May 2007–Oct 2016 AV ≤8 cm; LAR/ISR Open, Laparoscopic, TaTME PI, ISD, SCD, PO, ITD, Pubic length, Multiple pelvic angles, Lateral pelvic floor muscle distance, Distance/angle from simulated trocar position, Transverse distance, AP distance, Prostate size, Tumour size TME quality, Operative time, Blood loss, CRM involvement, Distal margin Univariate analysis and multivariable logistic regression ISD
McKechnie 2022 Canada Single‐centre 83 Jan 2015–Dec 2019 cStage I–III; LAR Laparoscopic, TaTME ISD, Mesorectal area, Rectal area, Transverse distance, AP distance, Pelvic area Operative time Univariate analysis and multivariable linear regression Posterior mesorectal thickness
Salerno 2006 UK 12 186 Jan 2002–Oct 2003 AV ≤16 cm; TME NR PI, ISD, SCD, PO, ITD, Pubic length, Multiple pelvic angles, Pelvic depth, S1/S3 distance, S3/Coccyx distance Male sex (surrogate of surgical difficulty) Univariate analysis and measurement reproducibility assessment ISD, ITD
Salerno 2007 UK 12 186 Jan 2002–Oct 2003 AV ≤16 cm; TME NR PI, SCD, PO, Pubic length, Multiple pelvic angles, Pelvic depth, S1/S3 distance, S3/Coccyx distance CRM involvement Univariate analysis and measurement reproducibility assessment None
Simpson 2020 UK Single‐centre 122 Jan 2014–Dec 2017 TME Open, Laparoscopic, Robotic PI, ISD, SCD, PO, Pubic length, Sacral depth, Sacrococcygeal angle, Sacrococcygeal curve area Specimen quality, CRM involvement, Operative time Univariate analysis and multivariable linear and logistic regression SCD, Sacrococcygeal angle
Sun 2021 China Single‐centre 294 2014–2016 AV ≤10 cm; cT3–4/N+; LAR/ISR; nCRT Laparoscopic PI, ISD, SCD, PO, Pubic length, Sacral depth, Multiple pelvic angles, Pelvic depth, Mesorectal area, Rectal area Operative time, Blood loss, Conversion to open, Transanal conversion, Postoperative complications, Length of hospital stay Univariate analysis and multivariable logistic regression with nomogram development ISD
Sun 2023 China Single‐centre 108 Mar 2019–Oct 2022 AV ≤12 cm Laparoscopic Iliac bone morphology, Sacrococcygeal morphology (manual segmentation) Surgeon‐rated difficulty, TME quality Predictive score development followed by deep learning–based model validation NA (deep learning model)
Teng 2022 China Single‐centre 214 Jan 2018–Dec 2020 AV ≤10 cm; LAR/ISR Laparoscopic PI, ISD, SCD, PO, ITD, Sacral depth, Pelvic depth, Pubococcygeal distance, Anorectal angle, Sacrococcygeal angle Operative time, Postoperative complications Univariate analysis and multivariable logistic regression PI, ITD, Pelvic depth
Tsuruta 2017 Japan Single‐centre 43 Jul 2007–Jan 2013 Male; LAR with DST Laparoscopic PI, ISD, SCD, PO, ITD, Seminal vesicle/S4 distance, S4/Anus depth, Mesorectal area, Transverse distance, Rectal area Anastomotic complications (AL) Univariate analysis and multivariable regression with ROC analysis ISD, Mesorectal thickness, S4/Anus depth
Yamamoto 2020 Japan Single‐centre 121 Jul 2005–Jun 2017 AV ≤10 cm; LAR/ISR Laparoscopic, Robotic PI, ISD, SCD, PO, ITD, Sacral depth, Anorectal angle, Pubococcygeal distance Operative time, Blood loss, Conversion to open, Transanal conversion, Postoperative complications, Length of hospital stay Univariate analysis and multivariable logistic regression PO, Anorectal angle
Yamaoka 2019 Japan Single‐centre 98 Jan 2010–Dec 2016 LAR Robotic PI, ISD, SCD, PO, Pubic length, Sacral depth, Multiple pelvic angles, Mesorectal area, Rectal area, Transverse distance Pelvic dissection time Univariate analysis and multivariable linear regression Mesorectal area
Yuan 2022 China Single‐centre 122 Jun 2010–Aug 2021 AV ≤10 cm; cStage I–III; LAR/ISR Open PI, ISD, SCD, PO, ITD, Transverse distance Operative time, Blood loss, Length of hospital stay, Postoperative complications Univariate analysis and multivariable logistic regression with nomogram and ROC analysis PI, ITD

Abbreviations: AL, anastomotic leakage; AP, anteroposterior; AV, anal verge; China, People's Republic of China; CRM, circumferential resection margin; DST, double‐stapling technique; ISD, interspinous distance; ISR, intersphincteric resection; ITD, intertuberous distance; LAR, low anterior resection; NA, not applicable; nCRT, neoadjuvant chemoradiotherapy; nCT, neoadjuvant chemotherapy; NR, not reported; PI, pelvic inlet; PO, pelvic outlet; ROC, receiver operating characteristic; SCD, sacrococcygeal distance; TaTME, transanal total mesorectal excision; TME, total mesorectal excision; UK, United Kingdom; USA, United States of America.

Risk‐of‐bias assessment

The results of the risk‐of‐bias assessment using the ROBINS‐E tool are summarised in Figure 2. Five studies were classified as having a high risk of bias in the confounding domain (Domain 1) because of a failure to implement multivariable analyses or adjustment models for important clinical confounders, including sex, tumour height, or BMI. Most studies exhibited some concerns regarding bias in exposure measurement (Domain 2), primarily because of the manual nature of the pelvimetric measurements. Twenty‐six single‐centre studies were classified as having some concerns regarding bias in participant selection (Domain 3), primarily because of the limited representativeness inherent in single‐centre designs. Similarly, most studies raised some concerns regarding bias due to post‐exposure interventions (Domain 4), given the potential influence of intraoperative technical performance and decision‐making on surgical outcomes. Collectively, 30 studies were characterised as having some concerns, five as having a high risk of bias, and one as providing insufficient information, reflecting inherent structural limitations in observational pelvimetric research rather than suboptimal study conduct per se.

FIGURE 2.

FIGURE 2

Results of the risk‐of‐bias assessment using the Risk of Bias in Non‐randomised Studies of Exposures (ROBINS‐E) tool.

Pelvimetry and surgical difficulty metrics

The MRI‐based pelvimetric parameters evaluated across the 36 included studies are summarised in Figure 3A, with representative sagittal and axial MRI pelvimetric measurements shown in Figure 4. Sagittal plane measurements included pelvic inlet (PI) in 27 studies, sacrococcygeal distance (SCD) in 24 studies, pelvic outlet (PO) in 23 studies, pubic length in 14 studies, sacral depth in 12 studies, and pelvic depth in 10 studies (Figure 4A). Axial plane measurements included interspinous distance (ISD) in 27 studies (Figure 4B), intertuberous distance (ITD) in 21 studies (Figure 4C), transverse pelvic distance in 10 studies (Figure 4D), and area‐based parameters, including mesorectal area in 13 studies and rectal area in 10 studies (Figure 4B).

FIGURE 3.

FIGURE 3

Results of the systematic review and evidence synthesis. (A) MRI‐based pelvimetric parameters evaluated in the included studies. (B) Surrogate outcomes used to represent surgical difficulty in the included studies. (C) MRI‐based pelvimetric parameters and the number of studies reporting significant associations with surrogate measures of surgical difficulty. PI, pelvic inlet; ISD, interspinous distance; SCD, sacrococcygeal distance; PO, pelvic outlet; ITD, intertuberous distance; CRM, circumferential resection margin; TME, total mesorectal excision; LN, lymph node.

FIGURE 4.

FIGURE 4

Representative examples of MRI‐based pelvimetric measurements in the sagittal and axial planes. (A) Sagittal plane measurements: Pelvic inlet (PI; distance between A and B), sacrococcygeal distance (SCD; distance between B and D), pelvic outlet (PO; distance between D and E), pubic length (distance between A and E), sacral depth (perpendicular distance from line AB to the deepest point of the sacrum), pelvic depth (perpendicular distance from line AB to point D), and sacrococcygeal angle (angle BCD). (B) Axial plane measurements: Yellow line, interspinous distance (ISD); blue area, mesorectal area; green area, rectal area. (C) Axial plane measurement of intertuberous distance (ITD). (D) Axial plane measurement of transverse pelvic distance.

The surrogate outcomes used to represent surgical difficulty across the 36 included studies are summarised in Figure 3B. Operating time, including total operating time and pelvic dissection time, was the most commonly reported surrogate outcome (22/36 studies). Other intraoperative outcomes were frequently assessed, including blood loss (13/36 studies), conversion to open surgery (8/36 studies), and conversion to transanal dissection (6/36 studies). Among the reported pathological outcomes, circumferential resection margin (CRM) involvement (12/36 studies) and TME quality (9/36 studies) were the most common. Postoperative outcomes, including global and anastomotic complications (19 studies) and length of hospital stay (9 studies), were also commonly evaluated.

Significant associations between pelvimetric parameters and surgical difficulty in individual studies are summarised in Figure 3C. ISD was most frequently reported to be significantly associated with surrogate measures of surgical difficulty (15/36 studies), followed by ITD (10/36 studies).

Meta‐analysis

Results of the meta‐analysis are presented in Figure 5. The meta‐analysis included six studies comprising 769 patients that used composite measures reflecting surgical difficulty. These measures comprised intraoperative and postoperative parameters, including operating time, blood loss, conversion or additional surgical approaches, and postoperative outcomes such as hospital stay and morbidity. PI, PO, SCD, ISD and ITD were selected as MRI‐based pelvimetric parameters of interest. A shorter ISD was significantly associated with increased surgical difficulty (MD −5.13, 95% CI −6.61 to −3.65; p < 0.001), without substantial heterogeneity (I 2 = 0%). A shorter ITD was also significantly associated with increased surgical difficulty (MD −7.32, CI −10.24 to −4.39; p = 0.004), without substantial heterogeneity (I 2 = 0%). PI, PO and SCD were not significantly associated with surgical difficulty.

FIGURE 5.

FIGURE 5

Forest plots of meta‐analysis results for MRI‐based pelvimetric parameters: (A) pelvic inlet (PI); (B) pelvic outlet (PO); (C) sacrococcygeal distance (SCD); (D) interspinous distance (ISD); (E) intertuberous distance (ITD).

DISCUSSION

In this systematic review, we synthesised studies evaluating the ability of preoperative MRI‐based pelvimetry to predict surgical difficulty in rectal cancer surgery following TME. We comprehensively reviewed MRI‐based pelvimetric parameters and surrogate measures of surgical difficulty reported in the existing literature. Among the pelvimetric parameters, PI, ISD, SCD, PO and ITD were the most frequently adopted measures. Meta‐analysis demonstrated that shorter ISD and ITD, two frequently reported parameters, were significantly associated with greater surgical difficulty. Although numerous pelvimetric parameters have been proposed, no consensus has emerged regarding which measures are most informative. Our findings may help identify promising targets for future research. Notably, pelvimetric parameters in the majority of included studies were obtained manually, a practice known to introduce substantial inter‐ and intra‐observer variability. To overcome these limitations, the integration of advanced medical image analysis, particularly foundation models, may facilitate automated or semi‐automated measurements, thereby improving the reliability and reproducibility of pelvimetric assessments.

Surrogate measures of surgical difficulty varied widely, encompassing intraoperative metrics, postoperative clinical outcomes and pathological outcomes. This substantial heterogeneity indicates that no single measure adequately captures surgical difficulty. Instead, these findings support the development of composite measures that integrate multiple domains to more comprehensively reflect the multifaceted nature of surgical difficulty. Furthermore, composite outcomes could potentially be constructed using weighted averaging methods, with weights derived dynamically from frequently used indicators to reflect their relative informativeness.

In recent years, rectal cancer management has become increasingly complex with the availability of multiple surgical approaches and neoadjuvant treatment strategies. As treatment selection becomes increasingly individualised, accurate preoperative risk assessment has become more important. In this context, re‐examining the existing evidence on predictors of surgical difficulty is particularly relevant. Importantly, preoperative factors such as patient characteristics (e.g., age, sex and performance status) and preoperative therapies that may promote fibrosis or distort anatomical planes are potentially important determinants of surgical difficulty. These variables have not been adequately examined in previous studies and warrant further investigation in future surgical outcomes research.

Robotic TME and TaTME were introduced to address the limitations of conventional laparoscopic surgery, particularly the technical challenges posed by straight instruments and restricted manoeuvrability within a deep and narrow pelvis [29, 30, 31]. The articulated instruments of robotic systems and the bottom‐up perspective of the transanal approach both have the potential to mitigate pelvic anatomical constraints. In this review, no studies exclusively evaluated TaTME cohorts. Among studies limited to robotic TME, two of three did not demonstrate significant correlations between pelvimetric parameters and surrogate measures of surgical difficulty [32, 33, 34]. This observation suggests that robotic instrumentation may partially compensate for unfavourable pelvic anatomy; however, given the limited number of available studies, this finding should be interpreted with caution. Further data are required to clarify the role of pelvimetry in robotic TME and to determine whether similar or distinct patterns apply to TaTME.

A major source of potential bias identified in the included studies was the measurement of pelvimetric parameters. In most studies, distances, areas and angles were measured manually on MRI images. Such measurements are inherently operator‐dependent and susceptible to interobserver variability, potentially introducing measurement bias and limiting reproducibility across studies. AI‐based image analysis has emerged as a potential approach to address these limitations. Among the included studies, three employed deep learning‐based methods for MRI analysis [35, 36, 37]. Two of these studies used deep learning algorithms to automatically detect, segment and annotate target anatomical regions, thereby reducing reliance on manual landmark identification. These approaches may help standardise technically reproducible components of pelvimetry, including landmark detection, segmentation and geometric or volumetric measurements. However, the clinical interpretation of these measurements, particularly their relevance to surgical difficulty, will likely continue to require expert judgement.

Even with the identification of optimal pelvimetric parameters and the development of well‐structured composite surrogate outcomes, important limitations remain. Prediction models derived from single‐centre data sets are inherently limited in their generalisability and external validity and may not perform consistently when applied in other settings. In this review, 26 of the 36 included studies were single‐centre and were judged to have limited representativeness, reflecting an inherent limitation of this study design. Differences in patient characteristics, including obesity prevalence, MRI acquisition protocols and population‐level variation in pelvic morphology, may substantially affect model performance across institutional and geographic settings. Therefore, international multicentre studies are essential for developing robust and generalisable predictive models of surgical difficulty. The integration of diverse datasets across populations and imaging platforms will be critical for developing scalable and clinically applicable prediction models.

Finally, surgical outcomes are influenced by a combination of patient‐related factors and surgeon skill or technical efficiency. Although most included studies focused on patient‐level characteristics, intraoperative factors related to surgeon performance may also contribute substantially to patient outcomes and warrant systematic investigation in future studies. In addition, most studies employed conventional statistical approaches to evaluate associations between patient and treatment factors. However, these methods may not adequately capture complex interactions among variables that exert multiplicative effects on surgical outcomes. Machine learning techniques, paired with feature‐importance analyses, may better identify the most influential predictors of surgical outcomes. Such approaches may also enable the development of patient ‘personas’, defined by clusters of co‐occurring high‐impact features, which could serve as screening tools for personalised surgical risk prediction. Future prospective trials and multicentre registries could integrate MRI‐based pelvimetry, AI‐driven analytics and standardised surgical difficulty scores to enable harmonised risk stratification and externally validated prediction models.

This review had several limitations. First, because standardised definitions and outcome measures for surgical difficulty are lacking, direct quantitative comparison or prioritisation of individual pelvimetric parameters was not feasible. Although this review aimed to map the range of parameters and surrogate outcomes reported in the literature, such heterogeneity limits conclusions regarding their relative importance. These findings highlight the need for future consensus efforts, potentially using a structured Delphi process, to establish standardised definitions and outcome measures for surgical difficulty in TME for rectal cancer. Second, most included studies were retrospective and exploratory, precluding causal inference regarding the relationship between pelvic anatomy and surgical difficulty. Potential confounding factors, including surgeon experience, tumour characteristics and treatment strategies, were addressed inconsistently across studies. Third, the majority of studies were conducted at single centres, thereby limiting generalisability and external validity. Fourth, ongoing technological advances, including robotic surgery and AI‐based image analysis, may alter the relevance of traditional pelvimetric parameters over time, thereby complicating cross‐study interpretation.

Despite these limitations, this review provides a structured synthesis of heterogeneous pelvimetric parameters, surrogate outcomes and analytical approaches that may inform future research. Specifically, these findings provide a foundation for selecting appropriate pelvimetric parameters and outcome measures and for developing standardised, methodologically robust study designs to predict surgical difficulty.

CONCLUSIONS

This systematic review demonstrated that ISD, ITD, PI, PO and SCD are the most frequently evaluated preoperative MRI‐based pelvimetric parameters for predicting surgical difficulty in TME for rectal cancer. Meta‐analysis demonstrated that shorter ISD and ITD were significantly associated with surrogate measures of surgical difficulty. Across the included studies, surgical difficulty was assessed using a wide range of surrogate outcomes, highlighting the need for well‐structured composite measures that integrate intraoperative metrics, postoperative clinical outcomes and pathological findings. Overall, this review synthesises the existing evidence to inform future study design and support the development of standardised pelvimetric assessments and outcome definitions for preoperative risk prediction, with potential implications for more individualised treatment strategies in rectal cancer.

AUTHOR CONTRIBUTIONS

Daichi Kitaguchi: Conceptualization; methodology; writing – original draft. Fiona R. Kolbinger: Writing – review and editing. Paul Dipanjyoti: Conceptualization; methodology; writing – review and editing; funding acquisition. Kshitij Jadhav: Writing – review and editing; supervision. Tatsuya Oda: Writing – review and editing; supervision. Antonello Forgione: Writing – review and editing; supervision. Jacques Marescaux: Writing – review and editing; resources; supervision.

FUNDING INFORMATION

This research was supported by the Japan Agency for Medical Research and Development (AMED) under Grant Number JP256f0137008. FRK receives support from the German Cancer Research Center (CoBot 2.0), the Central Indiana Corporate Partnership AnalytiXIN Initiative, the Evan and Sue Ann Werling Pancreatic Cancer Research Fund, and the Indiana Clinical and Translational Sciences Institute, funded in part by the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award (UM1TR004402). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. FRK declares an ongoing advisory role with the Surgical Data Science Collective, USA, and has received research funding from Novartis. All other authors declare that they have no relevant financial relationships.

CONFLICT OF INTEREST STATEMENT

The authors declare that they have no competing interests related to this work.

ETHICS STATEMENT

Not applicable. This study is a systematic review based on previously published data; therefore, ethical approval was not required.

PATIENT CONSENT STATEMENT

Patient consent was not required because this study is a systematic review based exclusively on previously published data and does not involve individual patient data.

PERMISSION TO REPRODUCE MATERIAL

No copyrighted material requiring permission for reproduction has been included in this manuscript.

Supporting information

Table S1: Search strategies for each database.

Table S2: References of studies included in the systematic review.

CODI-28-0-s002.docx (24.4KB, docx)

Data S1: PRISMA 2020 Checklist.

CODI-28-0-s001.docx (270.4KB, docx)

ACKNOWLEDGEMENTS

The authors would like to thank Editage (http://www.editage.com) for English‐language editing and review of this manuscript.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request.

REFERENCES

  • 1. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery—the clue to pelvic recurrence? Br J Surg. 1982;69(10):613–616. 10.1002/bjs.1800691019 [DOI] [PubMed] [Google Scholar]
  • 2. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1(8496):1479–1482. 10.1016/S0140-6736(86)91510-2 [DOI] [PubMed] [Google Scholar]
  • 3. van der Pas MH, Haglind E, Cuesta MA, Fürst A, Lacy AM, Hop WC, et al. Laparoscopic versus open surgery for rectal cancer (COLOR II): short‐term outcomes of a randomised, phase 3 trial. Lancet Oncol. 2013;14(3):210–218. 10.1016/S1470-2045(13)70016-0 [DOI] [PubMed] [Google Scholar]
  • 4. Bonjer HJ, Deijen CL, Abis GA, Cuesta MA, Van Der Pas MH, De Lange‐De Klerk ES, et al. A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med. 2015;372(14):1324–1332. 10.1056/NEJMoa1414882 [DOI] [PubMed] [Google Scholar]
  • 5. Kang SB, Park JW, Jeong SY, Nam BH, Choi HS, Kim DW, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short‐term outcomes of an open‐label randomised controlled trial. Lancet Oncol. 2010;11(7):637–645. 10.1016/S1470-2045(10)70131-5 [DOI] [PubMed] [Google Scholar]
  • 6. Jeong SY, Park JW, Nam BH, Kim S, Kang SB, Lim SB, et al. Open versus laparoscopic surgery for mid‐rectal or low‐rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open‐label, non‐inferiority, randomised controlled trial. Lancet Oncol. 2014;15(7):767–774. 10.1016/S1470-2045(14)70205-0 [DOI] [PubMed] [Google Scholar]
  • 7. Park JW, Kang SB, Hao J, Lim SB, Choi HS, Kim DW, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): 10‐year follow‐up of an open‐label, non‐inferiority, randomised controlled trial. Lancet Gastroenterol Hepatol. 2021;6(7):569–577. 10.1016/S2468-1253(21)00094-7 [DOI] [PubMed] [Google Scholar]
  • 8. Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M, et al. Effect of laparoscopic‐assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA. 2015;314(13):1346–1355. 10.1001/jama.2015.10529 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Fleshman J, Branda ME, Sargent DJ, Boller AM, George VV, Abbas MA, et al. Disease‐free survival and local recurrence for laparoscopic resection compared with open resection of stage II to III rectal cancer: follow‐up results of the ACOSOG Z6051 randomized controlled trial. Ann Surg. 2019;269(4):589–595. 10.1097/SLA.0000000000003002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Stevenson AR, Solomon MJ, Lumley JW, Hewett P, Clouston AD, Gebski VJ, et al. Effect of laparoscopic‐assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA. 2015;314(13):1356–1363. 10.1001/jama.2015.12009 [DOI] [PubMed] [Google Scholar]
  • 11. Stevenson AR, Solomon MJ, Brown CS, Lumley JW, Hewett P, Clouston AD, et al. Disease‐free survival and local recurrence after laparoscopic‐assisted resection or open resection for rectal cancer: the Australasian laparoscopic cancer of the rectum randomized clinical trial. Ann Surg. 2019;269(4):596–602. 10.1097/SLA.0000000000003021 [DOI] [PubMed] [Google Scholar]
  • 12. Feng Q, Yuan W, Li T, Tang B, Jia B, Zhou Y, et al. Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short‐term outcomes of a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol. 2022;7(11):991–1004. 10.1016/S2468-1253(22)00248-5 [DOI] [PubMed] [Google Scholar]
  • 13. Feng Q, Yuan W, Li T, Tang B, Jia B, Zhou Y, et al. Robotic vs laparoscopic surgery for middle and low rectal cancer: the REAL randomized clinical trial. JAMA. 2025;334(2):136–148. 10.1001/jama.2025.8123 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Liu H, Zeng Z, Zhang H, Wu M, Ma D, Wang Q, et al. Morbidity, mortality, and pathologic outcomes of transanal versus laparoscopic total mesorectal excision for rectal cancer short‐term outcomes from a multicenter randomized controlled trial. Ann Surg. 2023;277(1):1–6. 10.1097/SLA.0000000000005523 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Zeng Z, Luo S, Zhang H, Wu M, Ma D, Wang Q, et al. Transanal vs laparoscopic total mesorectal excision and 3‐year disease‐free survival in rectal cancer: the TaLaR randomized clinical trial. JAMA. 2025;333(9):774–783. 10.1001/jama.2024.24276 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Conroy T, Bosset JF, Etienne PL, Rio E, François É, Mesgouez‐Nebout N, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER‐PRODIGE 23): a multicentre, randomised, open‐label, phase 3 trial. Lancet Oncol. 2021;22(5):702–715. 10.1016/S1470-2045(21)00079-6 [DOI] [PubMed] [Google Scholar]
  • 17. Conroy T, Castan F, Etienne PL, Rio E, Mesgouez‐Nebout N, Evesque L, et al. Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long‐term results of the UNICANCER‐PRODIGE 23 trial. Ann Oncol. 2024;35(10):873–881. 10.1016/j.annonc.2024.06.019 [DOI] [PubMed] [Google Scholar]
  • 18. Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CA, Putter H, Kranenbarg EM, et al. Short‐course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open‐label, phase 3 trial. Lancet Oncol. 2021;22(1):29–42. 10.1016/S1470-2045(20)30555-6 [DOI] [PubMed] [Google Scholar]
  • 19. Garcia‐Aguilar J, Patil S, Gollub MJ, Kim JK, Yuval JB, Thompson HM, et al. Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol. 2022;40(23):2546–2556. 10.1200/JCO.22.00032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Verheij FS, Omer DM, Williams H, Lin ST, Qin LX, Buckley JT, et al. Long‐term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized phase II OPRA trial. J Clin Oncol. 2024;42(5):500–506. 10.1200/JCO.23.01208 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Hofheinz RD, Fokas E, Benhaim L, Price TJ, Arnold D, Beets‐Tan R, et al. Localised rectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow‐up. Ann Oncol. 2025;36(9):1007–1024. 10.1016/j.annonc.2025.05.528 [DOI] [PubMed] [Google Scholar]
  • 22. Hong JS, Brown KG, Waller J, Young CJ, Solomon MJ. The role of MRI pelvimetry in predicting technical difficulty and outcomes of open and minimally invasive total mesorectal excision: a systematic review. Tech Coloproctol. 2020;24(10):991–1000. 10.1007/s10151-020-02274-x [DOI] [PubMed] [Google Scholar]
  • 23. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. 10.1136/bmj.n71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Higgins JP, Morgan RL, Rooney AA, Taylor KW, Thayer KA, Silva RA, et al. A tool to assess risk of bias in non‐randomized follow‐up studies of exposure effects (ROBINS‐E). Environ Int. 2024;186:108602. 10.1016/j.envint.2024.108602 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS‐I: a tool for assessing risk of bias in non‐randomised studies of interventions. BMJ. 2016;355:i4919. 10.1136/bmj.i4919 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135. 10.1186/1471-2288-14-135 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid‐range, and/or mid‐quartile range. Stat Methods Med Res. 2018;27(6):1785–1805. 10.1177/0962280216669183 [DOI] [PubMed] [Google Scholar]
  • 28. Escal L, Nougaret S, Guiu B, Bertrand MM, De Forges H, Tetreau R, et al. MRI‐based score to predict surgical difficulty in patients with rectal cancer. Br J Surg. 2018;105(1):140–146. 10.1002/bjs.10642 [DOI] [PubMed] [Google Scholar]
  • 29. Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland J, et al. Effect of robotic‐assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: the ROLARR randomized clinical trial. JAMA. 2017;318(16):1569–1580. 10.1001/jama.2017.7219 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Deijen CL, Velthuis S, Tsai A, Mavroveli S, De Lange‐De Klerk ES, Sietses C, et al. COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer. Surg Endosc. 2016;30(8):3210–3215. 10.1007/s00464-015-4615-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Serra‐Aracil X, Zarate A, Bargalló J, Gonzalez A, Serracant A, Roura J, et al. Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta‐LaTME study): multicentre, randomized, open‐label trial. Br J Surg. 2023;110(2):150–158. 10.1093/bjs/znac324 [DOI] [PubMed] [Google Scholar]
  • 32. Baek SJ, Kim CH, Cho MS, Bae SU, Hur H, Min BS, et al. Robotic surgery for rectal cancer can overcome difficulties associated with pelvic anatomy. Surg Endosc. 2015;29(6):1419–1424. 10.1007/s00464-014-3818-x [DOI] [PubMed] [Google Scholar]
  • 33. Felsenreich DM, Gachabayov M, Bergamaschi R, RESURRECT Study Group . Does the mesorectal fat area impact the histopathology metrics of the specimen in males undergoing TME for distal rectal cancer? Updates Surg. 2023;75(3):581–588. 10.1007/s13304-022-01429-9 [DOI] [PubMed] [Google Scholar]
  • 34. Yamaoka Y, Yamaguchi T, Kinugasa Y, Shiomi A, Kagawa H, Yamakawa Y, et al. Mesorectal fat area as a useful predictor of the difficulty of robotic‐assisted laparoscopic total mesorectal excision for rectal cancer. Surg Endosc. 2019;33(2):557–566. 10.1007/s00464-018-6331-9 [DOI] [PubMed] [Google Scholar]
  • 35. Baltus SC, Geitenbeek RT, Frieben M, Thibeau‐Sutre E, Wolterink JM, Tan CO, et al. Deep learning‐based pelvimetry in pelvic MRI volumes for pre‐operative difficulty assessment of total mesorectal excision. Surg Endosc. 2025;39(3):1536–1543. 10.1007/s00464-024-11485-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Cai ZH, Zhang Q, Fu ZW, Fingerhut A, Tan JW, Zang L, et al. Magnetic resonance imaging‐based deep learning model to predict multiple firings in double‐stapled colorectal anastomosis. World J Gastroenterol. 2023;29(3):536–548. 10.3748/wjg.v29.i3.536 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Sun Z, Hou W, Liu W, Liu J, Li K, Wu B, et al. Establishment of surgical difficulty grading system and application of MRI‐based artificial intelligence to stratify difficulty in laparoscopic rectal surgery. Bioengineering (Basel). 2023;10(4):468. 10.3390/bioengineering10040468 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Table S1: Search strategies for each database.

Table S2: References of studies included in the systematic review.

CODI-28-0-s002.docx (24.4KB, docx)

Data S1: PRISMA 2020 Checklist.

CODI-28-0-s001.docx (270.4KB, docx)

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.


Articles from Colorectal Disease are provided here courtesy of Wiley

RESOURCES